$26.15
-0.36-1.36%
At close: Dec 15, 4:00 PM EST
$26.15
N/A
After Hours: 4:00 PM EST
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Comments
Loading...
Centessa Pharmaceuticals Insider Trading Activity
CNTANASDAQ
Centessa Pharmaceuticals Insider Trading Activity | NASDAQ:CNTA | Benzinga
Track the latest Centessa Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for Centessa Pharmaceuticals stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Centessa Pharmaceuticals PLC Insiders Doing?
At Centessa Pharmaceuticals PLC, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 15.00K shares worth $540.64K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On October 27, 2025, Alberto Mario Accardi, the company's PRESIDENT, OREXIN PROGRAM sold 3K shares for $16.5 each.
- On December 8, 2025, Alberto Mario Accardi, the company's PRESIDENT, OREXIN PROGRAM sold 5K shares for $19.77 each.
- On December 9, 2025, Alberto Mario Accardi, the company's PRESIDENT, OREXIN PROGRAM sold 10K shares for $28.83 each.
Ownership Statistics for Centessa Pharmaceuticals PLC
Shares Outstanding
147.820M
Insider Shares Owned
3.318M
Insider Percentage Owned
2.24%
Institutional Shares Held
27.820M
Institutional Percentage Held
18.8%
| Dec 09, 2025 | Alberto Mario Accardi | PRESIDENT, OREXIN PROGRAM | -10.00K | $28.83 | -$288.29K | SELL | -5.30% | 178.80K | Dec 09 | View |
| Dec 08, 2025 | Alberto Mario Accardi | PRESIDENT, OREXIN PROGRAM | -5.00K | $19.77 | -$252.35K | SELL | -2.58% | 188.80K | Dec 08 | View |
| Nov 18, 2025 | IQBAL HUSSAIN | GENERAL COUNSEL | 0.00 | $16.74 | -$130.80K | SELL-OPTIONS | 0.00% | 105.39K | Nov 17 | View |
| Nov 18, 2025 | Tia Bush | CHIEF TECHNOLOGY & QUALITY OFC | 0.00 | $18.71 | -$743.20K | SELL-OPTIONS | 0.00% | 121.50K | Nov 17 | View |
| Nov 13, 2025 | Tia Bush | CHIEF TECHNOLOGY & QUALITY OFC | 0.00 | $17.71 | -$663.20K | SELL-OPTIONS | 0.00% | 121.50K | Nov 12 | View |
| Oct 27, 2025 | Alberto Mario Accardi | PRESIDENT, OREXIN PROGRAM | -3.00K | $16.50 | -$159.95K | SELL | -1.52% | 194.39K | Oct 27 | View |
| Oct 16, 2025 | IQBAL HUSSAIN | GENERAL COUNSEL | 0.00 | $14.12 | -$99.40K | SELL-OPTIONS | 0.00% | 110.89K | Oct 15 | View |
| Sep 24, 2025 | Tia Bush | CHIEF TECHNOLOGY & QUALITY OFC | 0.00 | $16.71 | -$510.30K | SELL-OPTIONS | 0.00% | 121.50K | Sep 24 | View |
| Sep 16, 2025 | Alberto Mario Accardi | PRESIDENT, OREXIN PROGRAM | -8.17K | $21.40 | -$174.85K | SELL | -3.98% | 197.39K | Sep 16 | View |
| Sep 15, 2025 | IQBAL HUSSAIN | GENERAL COUNSEL | 0.00 | $13.85 | -$96.06K | SELL-OPTIONS | 0.00% | 110.89K | Sep 15 | View |
| Sep 11, 2025 | Tia Bush | CHIEF TECHNOLOGY & QUALITY OFC | 0.00 | $14.86 | -$611.76K | SELL-OPTIONS | 0.00% | 121.50K | Sep 09 - Sep 10 | View |
| Sep 11, 2025 | IQBAL HUSSAIN | GENERAL COUNSEL | 0.00 | $13.42 | -$606.50K | SELL-OPTIONS | 0.00% | 110.89K | Sep 09 - Sep 10 | View |
| Sep 11, 2025 | Alberto Mario Accardi | PRESIDENT, OREXIN PROGRAM | -2.00K | $14.00 | -$99.95K | SELL | -0.96% | 205.57K | Sep 09 | View |
| Aug 15, 2025 | IQBAL HUSSAIN | GENERAL COUNSEL | 0.00 | $11.54 | -$68.34K | SELL-OPTIONS | 0.00% | 110.89K | Aug 15 | View |
| Jul 30, 2025 | Alberto Mario Accardi | PRESIDENT, OREXIN PROGRAM | -8.32K | $15.23 | -$126.75K | SELL | -3.84% | 208.16K | Jul 29 | View |
| Jul 25, 2025 | Gregory M Weinhoff | CHIEF BUSINESS OFFICER | 0.00 | $9.70 | -$117.10K | SELL-OPTIONS | 0.00% | 122.28K | Jul 25 | View |
| Jul 21, 2025 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | 0.00 | $9.88 | -$663.85K | SELL-OPTIONS | 0.00% | 259.02K | Jul 21 | View |
| Jul 17, 2025 | IQBAL HUSSAIN | GENERAL COUNSEL | 0.00 | $10.38 | -$54.53K | SELL-OPTIONS | 0.00% | 110.89K | Jul 15 | View |
| Jun 25, 2025 | Gregory M Weinhoff | CHIEF BUSINESS OFFICER | 0.00 | $8.86 | -$100.14K | SELL-OPTIONS | 0.00% | 122.28K | Jun 25 | View |
| Jun 25, 2025 | IQBAL HUSSAIN | GENERAL COUNSEL | 0.00 | $9.93 | -$98.14K | SELL-OPTIONS | 0.00% | 110.89K | Jun 24 | View |
| Jun 25, 2025 | Alberto Mario Accardi | PRESIDENT, OREXIN PROGRAM | 0.00 | $8.93 | -$152.25K | SELL-OPTIONS | 0.00% | 216.49K | Jun 24 | View |
| Jun 20, 2025 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | 0.00 | $8.24 | -$483.08K | SELL-OPTIONS | 0.00% | 259.02K | Jun 20 | View |
| May 27, 2025 | Gregory M Weinhoff | CHIEF BUSINESS OFFICER | 0.00 | $8.34 | -$89.72K | SELL-OPTIONS | 0.00% | 122.28K | May 27 | View |
| May 20, 2025 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | 0.00 | $8.28 | -$487.36K | SELL-OPTIONS | 0.00% | 259.02K | May 20 | View |
| May 19, 2025 | ARJUN GOYAL | DIRECTOR | 462.58K | $12.68 | $5.87M | BUY | ∞ | 462.58K | May 15 - May 16 | View |
| May 02, 2025 | IQBAL HUSSAIN | GENERAL COUNSEL | 0.00 | $9.92 | -$2.54K | SELL-OPTIONS | 0.00% | 110.89K | May 01 | View |
| Apr 29, 2025 | IQBAL HUSSAIN | GENERAL COUNSEL | 0.00 | $9.92 | -$46.43K | SELL-OPTIONS | 0.00% | 110.89K | Apr 25 - Apr 28 | View |
| Apr 25, 2025 | Gregory M Weinhoff | CHIEF BUSINESS OFFICER | -11.74K | $13.61 | -$159.86K | SELL | -8.76% | 122.28K | Apr 25 | View |
| Apr 22, 2025 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | -55.00K | $12.39 | -$681.58K | SELL | -17.51% | 259.02K | Apr 21 - Apr 22 | View |
| Mar 26, 2025 | Gregory M Weinhoff | CHIEF BUSINESS OFFICER | 0.00 | $10.09 | -$124.89K | SELL-OPTIONS | 0.00% | 134.02K | Mar 25 | View |
| Mar 21, 2025 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | -55.00K | $16.69 | -$918.06K | SELL | -14.90% | 314.02K | Mar 20 | View |
| Mar 19, 2025 | DAVID CHAO | CHIEF ADMINISTRATIVE OFFICER | -3.50K | $10.51 | -$106.73K | SELL | -1.53% | 225.01K | Mar 17 | View |
| Mar 19, 2025 | IQBAL HUSSAIN | GENERAL COUNSEL | 0.00 | $11.14 | -$63.66K | SELL-OPTIONS | 0.00% | 110.89K | Mar 17 | View |
| Feb 26, 2025 | Gregory M Weinhoff | CHIEF BUSINESS OFFICER | -11.49K | $15.25 | -$175.27K | SELL | -7.90% | 134.02K | Feb 25 | View |
| Feb 20, 2025 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | -55.00K | $15.93 | -$876.09K | SELL | -12.97% | 369.02K | Feb 20 | View |
| Feb 19, 2025 | IQBAL HUSSAIN | GENERAL COUNSEL | 0.00 | $11.01 | -$62.03K | SELL-OPTIONS | 0.00% | 110.89K | Feb 18 | View |
| Feb 10, 2025 | Karen Anderson | CHIEF PEOPLE OFFICER | 0.00 | $11.52 | -$464.81K | SELL-OPTIONS | 0.00% | 54.32K | Feb 07 - Feb 10 | View |
| Feb 04, 2025 | Karen Anderson | CHIEF PEOPLE OFFICER | -17.20K | $16.90 | -$290.71K | SELL | -24.05% | 54.32K | Feb 01 - Feb 03 | View |
| Feb 04, 2025 | Tia Bush | CHIEF TECHNOLOGY & QUALITY OFC | -19.69K | $16.88 | -$332.49K | SELL | -13.95% | 121.50K | Feb 01 - Feb 03 | View |
| Jan 28, 2025 | Gregory M Weinhoff | CHIEF BUSINESS OFFICER | -11.74K | $16.47 | -$193.43K | SELL | -6.85% | 159.78K | Jan 27 | View |
| Jan 22, 2025 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | -55.00K | $15.77 | -$867.43K | SELL | -10.53% | 467.40K | Jan 21 | View |
| Jan 17, 2025 | IQBAL HUSSAIN | GENERAL COUNSEL | 0.00 | $10.56 | -$56.70K | SELL-OPTIONS | 0.00% | 123.77K | Jan 15 | View |
| Dec 26, 2024 | Gregory M Weinhoff | CHIEF BUSINESS OFFICER | 0.00 | $10.44 | -$131.90K | SELL-OPTIONS | 0.00% | 183.27K | Dec 26 | View |
| Dec 20, 2024 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | -55.00K | $17.44 | -$959.06K | SELL | -8.96% | 558.66K | Dec 20 | View |
| Dec 17, 2024 | Tia Bush | CHIEF TECHNOLOGY & QUALITY OFC | -9.61K | $10.64 | -$409.31K | SELL | -6.11% | 147.62K | Dec 16 - Dec 17 | View |
| Dec 17, 2024 | IQBAL HUSSAIN | GENERAL COUNSEL | -71.70K | $11.12 | -$1.24M | SELL | -35.32% | 131.28K | Dec 16 | View |
| Dec 17, 2024 | Karen Anderson | CHIEF PEOPLE OFFICER | 0.00 | $10.53 | -$220.49K | SELL-OPTIONS | 0.00% | 71.53K | Dec 13 - Dec 17 | View |
| Dec 06, 2024 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | 0.00 | $12.15 | -$1.10M | SELL-OPTIONS | 0.00% | 613.66K | Dec 06 | View |
| Nov 27, 2024 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | 0.00 | $12.04 | -$3.70K | SELL-OPTIONS | 0.00% | 613.66K | Nov 25 | View |
| Nov 27, 2024 | Gregory M Weinhoff | CHIEF BUSINESS OFFICER | 0.00 | $10.76 | -$138.10K | SELL-OPTIONS | 0.00% | 183.27K | Nov 25 | View |
| Nov 22, 2024 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | -55.00K | $11.42 | -$992.96K | SELL | -8.23% | 613.66K | Nov 20 - Nov 22 | View |
| Nov 15, 2024 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | 0.00 | $12.06 | -$398.40K | SELL-OPTIONS | 0.00% | 668.66K | Nov 13 | View |
| Oct 25, 2024 | Gregory M Weinhoff | CHIEF BUSINESS OFFICER | -11.74K | $15.38 | -$180.63K | SELL | -6.02% | 183.27K | Oct 25 | View |
| Oct 23, 2024 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | -55.00K | $15.70 | -$863.73K | SELL | -7.60% | 668.66K | Oct 21 - Oct 23 | View |
| Sep 27, 2024 | Gregory M Weinhoff | CHIEF BUSINESS OFFICER | -16.62K | $15.69 | -$260.72K | SELL | -7.44% | 206.75K | Sep 25 | View |
| Sep 20, 2024 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | -55.00K | $16.53 | -$908.99K | SELL | -6.75% | 759.92K | Sep 20 | View |
| Sep 12, 2024 | Gregory M Weinhoff | CHIEF BUSINESS OFFICER | 0.00 | $11.42 | -$334.80K | SELL-OPTIONS | 0.00% | 223.37K | Sep 10 | View |
| Sep 12, 2024 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | 0.00 | $11.18 | -$1.87M | SELL-OPTIONS | 0.00% | 814.92K | Sep 10 | View |
| Sep 09, 2024 | Gregory M Weinhoff | CHIEF BUSINESS OFFICER | 0.00 | $10.42 | -$229.00K | SELL-OPTIONS | 0.00% | 223.37K | Sep 09 | View |
| Aug 23, 2024 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | -46.65K | $12.30 | -$573.91K | SELL | -5.41% | 814.92K | Aug 23 | View |
| Aug 23, 2024 | Gregory M Weinhoff | CHIEF BUSINESS OFFICER | -30.00K | $12.24 | -$367.22K | SELL | -11.84% | 223.37K | Aug 22 - Aug 23 | View |
| Aug 22, 2024 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | -8.35K | $12.28 | -$102.55K | SELL | -0.96% | 861.58K | Aug 20 - Aug 22 | View |
| Mar 26, 2024 | Karen Anderson | CHIEF PEOPLE OFFICER | -6.16K | $7.91 | -$430.71K | SELL | -7.93% | 71.53K | Mar 25 | View |
| Feb 02, 2024 | Harris Rotman | SVP REGULATORY AFFAIRS | 29.13K | $8.15 | -$68.22K | GRANT | 86.94% | 62.63K | Feb 01 | View |
| Sep 22, 2023 | Harris Rotman | SVP REGULATORY AFFAIRS | 0.00 | $5.33 | -$72.00K | SELL-OPTIONS | 0.00% | 33.50K | Sep 20 | View |
| Jun 02, 2023 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -6.50K | $4.45 | -$28.95K | SELL | -0.82% | 783.07K | Jun 01 | View |
| May 26, 2023 | Tia Bush | CHIEF QUALITY OFFICER | -8.00K | $4.48 | -$35.87K | SELL | -4.85% | 157.10K | May 24 | View |
| May 02, 2023 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -6.80K | $4.42 | -$30.08K | SELL | -0.85% | 789.57K | May 01 | View |
| Apr 04, 2023 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -10.31K | $3.76 | -$38.83K | SELL | -1.28% | 796.37K | Mar 31 - Apr 03 | View |
| Mar 03, 2023 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -7.00K | $3.42 | -$23.97K | SELL | -0.86% | 806.68K | Mar 01 | View |
| Feb 03, 2023 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | 69.50K | $3.79 | -$29.20K | GRANT | 9.34% | 813.68K | Feb 01 | View |
| Jan 04, 2023 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -9.24K | $3.16 | -$29.17K | SELL | -1.21% | 751.91K | Dec 31 - Jan 04 | View |
| Dec 05, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -9.40K | $3.91 | -$36.74K | SELL | -1.22% | 761.15K | Dec 01 | View |
| Nov 03, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -9.70K | $4.03 | -$39.06K | SELL | -1.25% | 765.06K | Nov 01 | View |
| Oct 04, 2022 | DAVID CHAO | CHIEF ADMINISTRATIVE OFFICER | -7.57K | $4.00 | -$30.29K | SELL | -3.28% | 222.93K | Sep 30 - Oct 03 | View |
| Oct 04, 2022 | Thomas Templeman | CHIEF TECHNOLOGY OFFICER | -4.46K | $4.00 | -$17.84K | SELL | -3.18% | 135.79K | Sep 30 - Oct 03 | View |
| Oct 04, 2022 | DAVID GRAINGER | CHIEF INNOVATION OFFICER | -5.18K | $4.00 | -$20.74K | SELL | -0.55% | 936.08K | Sep 30 - Oct 03 | View |
| Oct 04, 2022 | Gregory M Weinhoff | CHIEF FINANCIAL OFFICER | -8.90K | $4.00 | -$35.63K | SELL | -3.71% | 231.10K | Sep 30 - Oct 03 | View |
| Oct 04, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -14.99K | $3.94 | -$59.09K | SELL | -1.90% | 774.76K | Sep 30 - Oct 03 | View |
| Oct 04, 2022 | IQBAL HUSSAIN | GENERAL COUNSEL | -8.29K | $4.00 | -$33.18K | SELL | -4.92% | 160.21K | Sep 30 - Oct 03 | View |
| Oct 04, 2022 | Javad Shahidi | CHIEF MEDICAL OFFICER | -6.07K | $4.00 | -$24.29K | SELL | -3.68% | 158.93K | Sep 30 - Oct 03 | View |
| Oct 04, 2022 | Tia Bush | CHIEF QUALITY OFFICER | -4.71K | $4.00 | -$18.87K | SELL | -3.18% | 143.29K | Sep 30 - Oct 03 | View |
| Sep 02, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -10.42K | $4.41 | -$45.99K | SELL | -1.30% | 789.75K | Sep 01 | View |
| Aug 03, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -10.42K | $4.45 | -$46.41K | SELL | -1.29% | 800.17K | Aug 01 | View |
| Jul 20, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -20.00K | $4.87 | -$97.31K | SELL | -2.41% | 810.60K | Jul 18 | View |
| Jul 06, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | 90.90K | $5.03 | -$45.80K | GRANT | 12.29% | 830.60K | Jul 01 | View |
| Jun 27, 2022 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | 10.00K | $4.63 | $46.28K | BUY | 35.71% | 38.00K | Jun 24 | View |
| Jun 21, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -9.20K | $4.68 | -$43.04K | SELL | -1.23% | 739.70K | Jun 17 | View |
| May 19, 2022 | ANTOINE YVER | EVP & CHAIRMAN DEVELOPMENT | -85.00K | $5.17 | -$439.73K | SELL | -10.19% | 748.90K | May 17 - May 18 | View |
| Feb 04, 2022 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | 5.00K | $9.74 | $48.70K | BUY | 21.74% | 28.00K | Feb 02 | View |
| Feb 01, 2022 | DAVID GRAINGER | CHIEF INNOVATION OFFICER | 27.50K | $9.05 | $248.75K | BUY | 3.38% | 841.26K | Jan 28 | View |
| Dec 06, 2021 | Francesco Rubertis De | DIRECTOR | 34.33K | $12.82 | $440.06K | BUY | 11.62% | 329.63K | Dec 02 | View |
| Dec 06, 2021 | Medicxi Ventures Management Jersey LtdMedicxi Growth I LPMedicxi Growth CoInvest I LPMedicxi Growth I GP Ltd | 10% OWNER | 34.33K | $12.82 | $440.06K | BUY | 11.62% | 329.63K | Dec 02 | View |
| Dec 02, 2021 | Francesco Rubertis De | DIRECTOR | 97.15K | $12.24 | $1.19M | BUY | 41.93% | 328.84K | Nov 30 - Dec 01 | View |
| Dec 02, 2021 | Medicxi Ventures Management Jersey LtdMedicxi Growth I LPMedicxi Growth CoInvest I LPMedicxi Growth I GP Ltd | 10% OWNER | 97.15K | $12.24 | $1.19M | BUY | 41.93% | 328.84K | Nov 30 - Dec 01 | View |
| Nov 30, 2021 | Francesco Rubertis De | DIRECTOR | 68.52K | $11.64 | $797.43K | BUY | 26.55% | 326.58K | Nov 26 - Nov 29 | View |
| Nov 30, 2021 | Medicxi Ventures Management Jersey LtdMedicxi Growth I LPMedicxi Growth CoInvest I LPMedicxi Growth I GP Ltd | 10% OWNER | 68.52K | $11.64 | $797.43K | BUY | 26.55% | 326.58K | Nov 26 - Nov 29 | View |
| Nov 18, 2021 | AARON KANTOFF | DIRECTOR | 10.00K | $11.98 | $119.85K | BUY | 20.00% | 60.00K | Nov 18 | View |
| Nov 18, 2021 | SAURABH SAHA | CHIEF EXECUTIVE OFFICER | 23.00K | $12.28 | $282.47K | BUY | ∞ | 23.00K | Nov 16 | View |
| Nov 18, 2021 | Tia Bush | CHIEF QUALITY OFFICER | 5.00K | $12.46 | $62.30K | BUY | 166.67% | 8.00K | Nov 16 | View |
| Jun 04, 2021 | Francesco Rubertis De | DIRECTOR | 2.53M | $20.00 | $12.00M | BUY | ∞ | 325.00K | Jun 02 | View |
| Jun 04, 2021 | DAVID CHAO | CHIEF ADMINISTRATIVE OFFICER | 500.00 | $20.00 | $10.00K | BUY | ∞ | 500.00 | Jun 02 | View |
| Jun 04, 2021 | Tia Bush | CHIEF QUALITY OFFICER | 3.00K | $20.00 | $60.00K | BUY | ∞ | 3.00K | Jun 02 | View |
| Jun 04, 2021 | Thomas Templeman | CHIEF TECHNOLOGY OFFICER | 250.00 | $20.00 | $5.00K | BUY | ∞ | 250.00 | Jun 02 | View |
| Jun 04, 2021 | IQBAL HUSSAIN | GENERAL COUNSEL | 8.50K | $20.00 | $170.00K | BUY | ∞ | 5.50K | Jun 02 | View |
| Jun 04, 2021 | ARJUN GOYAL | DIRECTOR | 3.93M | $20.00 | $15.00M | BUY | ∞ | 106.16K | Jun 02 | View |
| Jun 04, 2021 | Marella Thorell | CHIEF ACCOUNTING OFFICER | 1.00K | $20.00 | $20.00K | BUY | ∞ | 1.00K | Jun 02 | View |
| Jun 04, 2021 | Gregory Weinhoff | CHIEF FINANCIAL OFFICER | 10.00K | $20.00 | $200.00K | BUY | ∞ | 10.00K | Jun 02 | View |
| Jun 04, 2021 | Medicxi Ventures Management Jersey LtdMedicxi Growth I LPMedicxi Growth CoInvest I LPMedicxi Growth I GP Ltd | 10% OWNER | 2.53M | $20.00 | $12.00M | BUY | ∞ | 325.00K | Jun 02 | View |
| Jun 03, 2021 | GAP Bermuda LTDGENERAL ATLANTIC GENPAR BERMUDA LPrl Sa Lux Atlantic GeneralSCSp Lux GenPar Atlantic GeneralGeneral Atlantic Cooperatief LPSCSp Lux Partners Atlantic GeneralGeneral Atlantic Partners Bermuda EU LPGeneral Atlantic Partners Bermuda IV LPUA Cooperatief Atlantic GeneralBV UM Atlantic General | DIRECTOR | 1.50M | $20.00 | $30.00M | BUY | 18.33% | 9.68M | Jun 02 | View |
FAQ
Q
Is insider trading legal?
A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q
What are some examples of market manipulation?
A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
CNTA Insider Trading News
No news found
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved